Literature DB >> 35864902

Protocol for High Throughput Screening of Antibody Phage Libraries.

Vanshika Singh1, Sonal Garg1, Nisha Raj1, Asha Lukose1, Deepti Jamwal1, Reshma Perween1, Samridhi Dhyani1, Hilal Ahamed Parray1, Chandresh Sharma1, Rajesh Kumar1,2.   

Abstract

Phage display is a proven and widely used technology for selecting specific antibodies against desired targets. However, an immense amount of effort is required to identify and screen the desired positive clones from large and diverse combinatorial libraries. On the other hand, the selection of positive binding clones from synthetic and semi-synthetic libraries has an inherent bias toward clones with randomly produced amber stop codons, making it more difficult to identify desirable binding antibodies. To overcome the screening of desired clones with amber codons, we present a step-by-step approach for effective phage library screening to isolate useful antibodies. The procedure calls for creating a simple new vector system for soluble production of phage ELISA positive binding clones with one or more amber stop codons in their single-chain antibody fragment (scFv) gene sequences, which is otherwise difficult in standard screening. Graphical abstract.
Copyright © 2022 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Amber codon; High-throughput screening; Novel vector system; Phage display; scFv

Year:  2022        PMID: 35864902      PMCID: PMC9257838          DOI: 10.21769/BioProtoc.4450

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  10 in total

1.  Identification and repair of positive binding antibodies containing randomly generated amber codons from synthetic phage display libraries.

Authors:  Warren D Marcus; Stuart M Lindsay; Michael R Sierks
Journal:  Biotechnol Prog       Date:  2006 May-Jun

Review 2.  Phage display antibody libraries: A robust approach for generation of recombinant human monoclonal antibodies.

Authors:  Rajesh Kumar; Hilal Ahmed Parray; Tripti Shrivastava; Subrata Sinha; Kalpana Luthra
Journal:  Int J Biol Macromol       Date:  2019-06-03       Impact factor: 6.953

3.  Isolation and Characterization of Cross-Neutralizing Human Anti-V3 Single-Chain Variable Fragments (scFvs) Against HIV-1 from an Antigen Preselected Phage Library.

Authors:  Rajesh Kumar; Ruchi Kumari; Lubina Khan; Anurag Sankhyan; Hilal Ahmad Parray; Ashutosh Tiwari; Naveet Wig; Subrata Sinha; Kalpana Luthra
Journal:  Appl Biochem Biotechnol       Date:  2018-08-28       Impact factor: 2.926

4.  A fast mutagenesis procedure to recover soluble and functional scFvs containing amber stop codons from synthetic and semisynthetic antibody libraries.

Authors:  Rodrigo Barderas; Susana Shochat; Jorge Martínez-Torrecuadrada; Danièle Altschuh; Rob Meloen; Jose Ignacio Casal
Journal:  J Immunol Methods       Date:  2006-04-21       Impact factor: 2.303

5.  A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single-chain antibody fragments.

Authors:  Reshma Perween; Shubbir Ahmed; Tripti Shrivastava; Hilal A Parray; Balwant Singh; Kamal S Pindari; Chandresh Sharma; Shivangi Shukla; Subrata Sinha; Anil Kumar Panchal; Rajesh Kumar
Journal:  Biotechnol Prog       Date:  2021-02-23

Review 6.  Phage display-derived human antibodies in clinical development and therapy.

Authors:  André Frenzel; Thomas Schirrmann; Michael Hust
Journal:  MAbs       Date:  2016-07-14       Impact factor: 5.857

Review 7.  Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.

Authors:  Hilal Ahmed Parray; Shivangi Shukla; Sweety Samal; Tripti Shrivastava; Shubbir Ahmed; Chandresh Sharma; Rajesh Kumar
Journal:  Int Immunopharmacol       Date:  2020-05-27       Impact factor: 4.932

Review 8.  Advances in the Production and Batch Reformatting of Phage Antibody Libraries.

Authors:  Rose H Reader; Robert G Workman; Ben C Maddison; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

9.  A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C.

Authors:  Rajesh Kumar; Raiees Andrabi; Ashutosh Tiwari; Somi Sankaran Prakash; Naveet Wig; Durgashree Dutta; Anurag Sankhyan; Lubina Khan; Subrata Sinha; Kalpana Luthra
Journal:  BMC Biotechnol       Date:  2012-11-15       Impact factor: 2.563

Review 10.  Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes.

Authors:  Jens Markus Borghardt; Charlotte Kloft; Ashish Sharma
Journal:  Can Respir J       Date:  2018-06-19       Impact factor: 2.409

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.